Speech-Language Pathologists in Johnston, RI Accepting Medicare
6 Speech-Language Pathologists found. Showing 1 - 6
 Susan Boelger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1516 Atwood Ave, Johnston, RI 02919 Phone: 401-553-1000 Fax: 401-553-1146 |
Sara Nolette, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Almond Dr, Johnston, RI 02919 Phone: 401-639-0996 |
Jill Iuliano, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1516 Atwood Ave, Johnston, RI 02919 Phone: 401-553-1000 Fax: 401-553-1146 |
Ms. Lea Faye Jendza, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1516 Atwood Ave, Johnston, RI 02919 Phone: 401-785-2666 |
Michelle Marie Austin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Spring Dr, Johnston, RI 02919 Phone: 401-486-7697 |
Gianna Bordieri Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Ann Dr, Johnston, RI 02919 Phone: 401-447-8866 |
News Archive
Two Zika vaccine candidates protect newborn mice against neurological damage
Two vaccines against Zika virus developed at the University of Pittsburgh School of Medicine have successfully conveyed immunity from female mice to pups conceived weeks after the mother's vaccination.
First Edition: November 14, 2011
In today's headlines, reports about the Supreme Court's expected health law announcement; about where things stand with the super committee and its fast-approaching deadline; and other health policy news.
GW researchers partner with Grassroot Project to educate D.C. youth about HIV/AIDS
The George Washington School of Public Health and Health Services has partnered with the Grassroot Project, an organization of NCAA Division I varsity athletes using the universal language of sports to engage youth in educational outreach about HIV/AIDS. GW researchers are working with the Grassroot Project to develop and implement a sustainable monitoring and evaluation plan.
Epizyme announces publication of EZH2 enzyme for lymphoma in PNAS
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
› Verified 4 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Podiatrists
Audiologists